msemporda

Pages

  • Home
  • Pluripotent Science
  • Adult Cell Science
  • Genetics
  • Cancer
  • BLOOD
  • Exosomes
  • CIRM
  • JAPAN iPSCs
  • CYNATA
  • FATE
  • BIOTIME
  • BLUEROCK
  • AIRM (OCATA)
  • PLATELET BIO
  • ISSCR
  • UC London
  • Advocacy
  • Videos
  • About

The Science and Ethics of Genetically Engineered Human DNA - Congressional Hearing

Backstory and current state-of-play review in a formal setting w/ Q&A - Via Paul Knoepfler's Blog post: "Doudna & Others Testify Before Congress on CRISPR, Human Germline Editing"

Cheers





Posted by @msemporda - Michael Cea
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Labels: brain, Crispr Cas9, DNA, Egg, Embryo, Embryonic, ethics, genes, Genetics, handicapped, human rights, infertility, Mutations, Pre-Embryo, somatic cell, Sperm, stem cells, synthetic biology, Talen, Zinc Finger
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Most Recent Blog Posts In:

  • JAPAN iPSCs
  • Exosomes
  • PLATELET BIO
  • BLUEROCK
  • Home
  • Genetics
  • FATE
  • BLOOD
  • CIRM
  • CYNATA
  • BIOTIME
  • Pluripotent Science
  • Advocacy
  • Eye Research

Featured Coverage

  • Cancer
  • Exosomes
  • The Pluripotency Trilogy
  • The Coming of Age of Pluripotent Science & Musings...
  • Utility by Design - Bio-Engineered MedTech Devices
  • Germline Science & Embryo Use - The Law & Scope fo...
  • Masayo Takahashi - "Hope - Yes" & "Patients First"
  • Jeanne Loring - Parkinson's, Mice, DNA, hPSC & Rhinos
  • Sally Temple - Cells, Leadership & Audacious Innovation
View ms emporda's profile on LinkedIn

Michael Cea - About Me

@msemporda - Michael Cea
Marketing & public communications reporter & editor, with a hands-on business development history in mediatech and investigative analysis in the emerging field of cellular bio-sciences. Dedicated to disseminating the transformative science of cell based therapeutics through digital advocacy and outreach projects. Cheers
View my complete profile

Scoopit Curated Feed

Twitter Feed

Tweets by @msemporda

Highlighted Post

Balancing Paradigms with Mesenchymal Stromal Cells

Steve Gschmeissner/Science Photo Library Innovation isn't uniquely devoid of commonality of adoption by discipline. Rather the  lik...

Home Page Posts

  • The Hemangioblast Progeny - Ocata's Blood, Immune & Cancer Programs
    When we speak of the various programs Ocata has in development, apart from the Eye, they are referred to as "other" and are sep...
  • Pluripotent Stem Cells - OCATA's Broad Scientific Positioning
    Stem cell science is inherently complex as it relates to biological systems which are only now becoming fully explored and understood. ...
  • Sally Temple - Cells, Leadership & Audacious Innovation
    The eye is often referred to as the window into the soul. Whether that is true or not depends I suppose on who’s doing the viewing, as t...
  • The Rise of Germline Science - Human DNA Modification
    G enetic modification of human DNA to correct disease causing code has long been a stated goal of medical science. Ever since the discove...
  • Creation, Ensoulment, Birth & The Ethical Use of a Donated Cell
    “ School of Athens ” by Rafael w/ Plato and Aristotle - referred to by Pope Francis during EU Parliamentary address Nov 25, 2014 There ...
  • NaŃ—ve Human Pluripotency & The Broad Shoulders of Science
    Stevenage, UK BioScience Campus Scientific debate in the pursuit of knowledge by way of accumulated evidential data is fundamental, jus...
  • Cynata & The Rubik of Cell Science
    As with the sun rising in the East so have the first two pioneering programs using Induced Pluripotent Stem Cell (iPSC) technology for huma...
  • Germline Science & Embryo Use - The Law & Scope for Applied Research
    NIH statement on editing human embryo DNA The  recent reiteration by the Director of the NIH, Dr. Francis Collins, that the long ...
  • Early Safety and Efficacy Data in Cynata’s Phase 1 Trial of CYP-001 in GvHD
    Encouraging Early Safety and Efficacy Data in Cynata’s Phase 1 Trial of CYP-001 in GvHD; DSMB Recommendation to Initiate Enrolment of Secon...
  • Balancing Paradigms with Mesenchymal Stromal Cells
    Steve Gschmeissner/Science Photo Library Innovation isn't uniquely devoid of commonality of adoption by discipline. Rather the  lik...

Recommended Blogs

  • California Stem Cell Report
    The California Stem Cell Report Has Moved
  • Irv Arons' Journal
    The Soft Contact Lens Industry and My Role in its Growth: The Interesting Adventures of A Consultant
  • Knoepfler Lab Stem Cell Blog. UC Davis School of Medicine
    FDA shakeup finally gets Nicole Verdun; bros, politics & AI to rule?
  • Signals Blog
    New turn for stem cell therapy: How tiny messengers are about to change the game
  • Stem Cell Assays
    Cell therapy trials data
  • Stem Cell Battles
    AMERICA NEEDS PUBLIC BROADCASTING
  • The Stem Cellar
    Neurona Doses First Patient in CIRM-Funded Bilateral Epilepsy Cell Therapy Trial

Sector Reference Sites

  • ISSCR Closer Look @ Stem Cells
  • Alliance of Regenerative Medicine
  • Harvard Stem Cell Institute
  • NY Stem Cell Foundation
  • EuroStemCell Hub
  • Genetics Policy Institute
  • LifeMap Discovery

Blog Archive

  • ►  2022 (1)
    • ►  November (1)
  • ►  2019 (2)
    • ►  August (1)
    • ►  April (1)
  • ►  2018 (4)
    • ►  November (2)
    • ►  August (1)
    • ►  January (1)
  • ►  2017 (2)
    • ►  January (2)
  • ►  2016 (3)
    • ►  August (1)
    • ►  March (1)
    • ►  February (1)
  • ▼  2015 (10)
    • ►  November (1)
    • ►  October (1)
    • ►  August (1)
    • ►  July (2)
    • ▼  June (1)
      • The Science and Ethics of Genetically Engineered H...
    • ►  May (1)
    • ►  April (1)
    • ►  March (1)
    • ►  January (1)
  • ►  2014 (3)
    • ►  October (1)
    • ►  September (1)
    • ►  May (1)
  • ►  2013 (2)
    • ►  May (1)
    • ►  March (1)

Selected Videos




Word Cloud Snapshot

Word Cloud Snapshot
  • Disclosure & Disclaimer

Search

Subscribe To

Posts
Atom
Posts
All Comments
Atom
All Comments
c 2014 msemporda. Picture Window theme. Powered by Blogger.